A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent PullbackThe Motley Fool • 11/05/24
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term GrowthBenzinga • 10/31/24
IDXX Q3 Earnings Top, '24 Sales View Down, Stock Dips in PremarketZacks Investment Research • 10/31/24
IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slowReuters • 10/31/24
Seeking Clues to Idexx (IDXX) Q3 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 10/28/24
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/21/24
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says AnalystBenzinga • 08/06/24
Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/06/24
The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX LaboratoriesZacks Investment Research • 08/06/24